Baseline genetic abnormalities and effectiveness of osimertinib treatment in patients with chemotherapy-naïve EGFR-mutated NSCLC based on performance status. - Taniguchi Y; Tamiya A; Osuga M; Harada D; Isa SI; Nakamura K; Mizumori Y; Shinohara T; Yanai H; Nakatomi K; Oki M; Mori M; et al. (BMC pulmonary medicine, 2024)